A Patient Decision Aid for Method of Early Abortion: a Randomized Control Trial
NCT05182008 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 365
Last updated 2025-02-21
Summary
Introduction: There are two options for women seeking early pregnancy termination in Canada; either surgical or medication abortion. When making a decision about which option is best for them, patient must consider their values as well as social resources and circumstances Patient decision aids (PtDAs) are tools to help patients make health-related decisions, particularly when no 'best' choice exist.
Our research team has developed an online interactive patient decision aid on method of abortion based on international standards for decision aid development. We would like to investigate whether it leads to improved decisional quality in patients seeking early abortion.
Methods: Phase 1 will be development of an abortion knowledge assessment tool. We will start by developing ten multiple choice questions based on information that is classically included in abortion education material. The goal is to ultimately include 5-7 well-performing questions in the trial. The ten questions will be sent to content experts to answer and rate. They will rate the questions on representativeness and importance. The questions will also be administered to community members without specific abortion knowledge. Results will be used to assess content validity and discriminator validity and revise the questionnaire.
Phase 2 will be a randomized trial of people seeking abortion at less than 63 days gestation. Those who wish to participate will be randomized either the decision aid (study group) or the standard abortion clinic website (control). They will then be asked to participate in a survey immediately after they are finished reviewing the decision aid or website to. This survey will include questions about their decision, demographics, medical history, and their level of knowledge about abortion methods (by administering the knowledge assessment tool described above). The evaluation of the decision making will be measured using the Decisional Conflict Score. Four weeks post procedure, participants will be contacted by e-mail again and asked to complete a second survey identifying which type of abortion they underwent along with an inventory of perceived adverse treatment effects, as well as completing a Satisfaction with Decision Scale (SWD)
Conditions
- Abortion in First Trimester
- Abortion Early
- Decision Aid
- Clinical Decision-making
- Abortion, Therapeutic
Interventions
- OTHER
-
Decision aid
Online interactive decision aid on method of early abortion
- OTHER
-
Usual care
Patients will be directed to the abortion clinic website
Sponsors & Collaborators
-
Dalhousie University
collaborator OTHER -
University of British Columbia
collaborator OTHER -
IWK Health Centre
collaborator OTHER -
Nova Scotia Health Authority
lead OTHER
Principal Investigators
-
Melissa Brooks · Dalhousie University
Study Design
- Allocation
- RANDOMIZED
- Purpose
- SUPPORTIVE_CARE
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Sex
- FEMALE
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2022-05-05
- Primary Completion
- 2024-03-01
- Completion
- 2024-04-01
Countries
- Canada
Study Locations
More Related Trials
-
Effects of Prior Induced Termination of Pregnancy on Complications and Pregnancy Outcomes.
NCT04183829 ·Status: RECRUITING
-
Medical Abortion With Mifepristone + Misoprostol (13 - 22 Weeks)
NCT01768299 ·Status: COMPLETED ·Phase: PHASE4
-
Mifepristone Versus Misoprostol for Cervical Preparation Prior to Surgical Abortion Between 11 to 15 Weeks
NCT01636063 ·Status: TERMINATED ·Phase: NA
-
Same-Day Mifepristone-Misoprostol Compared to Misoprostol Only for Surgical Abortion Cervical Preparation
NCT02412618 ·Status: COMPLETED ·Phase: PHASE4
-
Comparison of Telephone Follow-up With In-person Follow-up After Medical Abortion
NCT01943279 ·Status: COMPLETED ·Phase: NA
-
Feasibility of a Self-performed Urinary Test for the Follow-up on Medical Abortion
NCT02304835 ·Status: COMPLETED
-
Medication Abortion With Autonomous Self-Assessment Project
NCT05278780 ·Status: COMPLETED ·Phase: NA
-
Dextromethorphan as a Novel Non-opioid Adjunctive Agent for Pain Control in Medication Abortion
NCT03480009 ·Status: COMPLETED ·Phase: PHASE3
-
Misoprostol in Missed Abortion
NCT06818903 ·Status: NOT_YET_RECRUITING
-
Mifepristone Versus Laminaria Insertion for Cervical Preparation Prior to Surgical Abortion at 14-16 Weeks
NCT00986921 ·Status: COMPLETED ·Phase: NA
-
Non-surgical Alternatives to Treatment of Failed Medical Abortion
NCT02704481 ·Status: TERMINATED ·Phase: PHASE4
-
Factors Associated With the Absence of Contraception at Women Seeking a Voluntary Termination of Pregnancy
NCT04830007 ·Status: SUSPENDED
-
R U OK? The Acceptability and Feasibility of New Communication Technologies for Follow-up After Medical Abortion
NCT01362387 ·Status: COMPLETED ·Phase: NA
-
A Randomized Controlled Trial of Three Antibiotic Regimens for First Trimester Abortions
NCT02756403 ·Status: COMPLETED ·Phase: NA
-
Manual Versus Electric Vacuum Aspiration for Pregnancy Termination Between 10-14 Weeks
NCT03079622 ·Status: COMPLETED ·Phase: NA
-
Medical Abortion up to 10 Weeks Gestation at Home
NCT02191774 ·Status: COMPLETED
-
Second Trimester Labor Induction
NCT00592215 ·Status: WITHDRAWN ·Phase: PHASE1
-
Ulipristal Acetate for Cervical Preparation
NCT03802149 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Mifepristone Plus Misoprostol Versus Misoprostol Alone for 2nd Trimester Abortion (14 - 21 Weeks Last Menstrual Period (LMP))
NCT00969982 ·Status: COMPLETED ·Phase: NA
-
Acceptability of an Out-patient Regimen of Medical Abortion With Mifepristone and 800 Mcg Misoprostol Administered at 78-84 Days Gestation
NCT01856985 ·Status: COMPLETED ·Phase: PHASE4
-
Mifepristone Versus Osmotic Dilator Insertion for Cervical Preparation Prior to Surgical Abortion at 15-18 Weeks
NCT01436279 ·Status: COMPLETED ·Phase: PHASE3
-
A Pilot of an Outpatient Regimen of Medical Abortion With Mifepristone and Sublingual Misoprostol in the 11 and 12 Weeks
NCT02720991 ·Status: COMPLETED ·Phase: PHASE4
-
Exploring a Patient-centered Approach to Mifepristone Administration in Medical Abortion
NCT01811056 ·Status: COMPLETED ·Phase: NA
-
Prophylactic Analgesic and Antiemetic Regimen for Medical Abortion < 70 Days
NCT05819619 ·Status: TERMINATED ·Phase: EARLY_PHASE1
-
Medication Abortion for Pregnancy of Unknown Location
NCT04026789 ·Status: UNKNOWN ·Phase: NA